15-Year watch begins for patients who received experimental cancer cell therapy
NCT ID NCT06976736
Summary
This study will monitor 1,000 people for 15 years after they received an experimental T-cell therapy for blood cancers like leukemia. The goal is to track long-term safety and see how well the treatment continues to work over time. No new treatment is given in this study; researchers are simply observing participants who were treated in a previous trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
Contact
-
Mount Sinai
RECRUITINGNew York, New York, 10029-6696, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.